There’s a lot of similarities between the two but also one stark difference.
Millions of Americans may be eligible to get blockbuster GLP-1 drugs like Wegovy and Zepbound for a much lower price starting July 1 under Medicare’s GLP-1 Bridge program.
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
Medbridge, the leading digital health platform for clinician education, home exercise programs, and remote therapeutic monitoring (RTM), today announced a strategic partnership with Tandem RTM, a full ...